Nanosonics (ASX:NAN) nearly tripled its revenue and shaved its losses by well over half in FY12, thanks to strong sales of its lead product, disinfection tool Trophon EPR.
The company reported revenue for the financial year of $13 million, up 295% from FY11. The net loss for the year meanwhile fell 58% to $4.7 million.
Nanosonics attributed the gains to increased momentum behind Trophon EPR – an ultrasound high-level disinfection system for hospitals and other healthcare facilities – in its key markets.
In Australia and New Zealand, the installed base of Trophon EPR cabinets edged passed the 600 unit milestone.